Gene · 51592
Papers2,289
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,289
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinical and laboratory features between anti-TIF1γ dermatomyositis with and without malignancy: 37 case series and a review. | J Dermatol | 2024 | 39258818 | PubTator, text mining | PubMed |
| Prevalence and Clinical Implications of Autoantibodies in Juvenile Dermatomyositis: A Single-Center Experience From India. | J Clin Rheumatol | 2024 | 39167787 | PubTator, text mining | PubMed |
| Autoantibody testing in myositis: an update. | Curr Opin Rheumatol | 2024 | 39155767 | PubTator, text mining | PubMed |
| Differences in the autoantibody phenotypes and long-term outcomes between juvenile- and adult-idiopathic inflammatory myopathies. | Semin Arthritis Rheum | 2024 | 39142036 | PubTator, text mining | PubMed |
| Genome-scale CRISPR-Cas9 screen identifies host factors as potential therapeutic targets for SARS-CoV-2 infection. | iScience | 2024 | 39100693 | PubTator, text mining | PubMed |
| Over Activation of IL-6/STAT3 Signaling Pathway in Juvenile Dermatomyositis. | Rheumatol Ther | 2024 | 39073510 | PubTator, text mining | PubMed |
| Multi-Omics Characterization of E3 Regulatory Patterns in Different Cancer Types. | Int J Mol Sci | 2024 | 39062881 | PubTator, text mining | PubMed |
| Developmental dysplasia of the hip caused by homozygous TRIM33 pathogenic variant affecting downstream BMP pathway. | J Med Genet | 2024 | 39054052 | Swiss-Prot, curated | PubMed |
| CD39 Is Expressed on Functional Effector and Tissue-resident Memory CD8+ T Cells. | J Immunol | 2024 | 38975728 | PubTator, text mining | PubMed |
| Case report: Pneumatosis coli in an anti-TIF1-ɣ-positive dermatomyositis patient. | Int J Rheum Dis | 2024 | 38937988 | PubTator, text mining | PubMed |
| Sequence Alignment between TRIM33 Gene and Human Noncoding RNAs: A Potential Explanation for Paraneoplastic Dermatomyositis. | J Pers Med | 2024 | 38929849 | PubTator, text mining | PubMed |
| TIF1-γ Positive Dermatomyositis with Spontaneous Muscular Hematoma in the Context of Ovarian Cancer: A Novel Survival Case Report. | J Inflamm Res | 2024 | 38911988 | PubTator, text mining | PubMed |
| TRIM33 enhances the ubiquitination of TFRC to enhance the susceptibility of liver cancer cells to ferroptosis. | Cell Signal | 2024 | 38909931 | PubTator, text mining | PubMed |
| A Rare Case of Anti-TIF-1γ Antibody Positive Dermatomyositis in Adulthood. | J Investig Med High Impact Case Rep | 2024 | 38904327 | PubTator, text mining | PubMed |
| Investigating the disparities among drug categories in drug-induced dermatomyositis: A systematic review. | Semin Arthritis Rheum | 2024 | 38833729 | PubTator, text mining | PubMed |
| TRIM33 plays a critical role in regulating dendritic cell differentiation and homeostasis by modulating Irf8 and Bcl2l11 transcription. | Cell Mol Immunol | 2024 | 38822080 | PubTator, text mining | PubMed |
| Anti-TIF1-γ-associated dermatomyositis associated with recurrent metastatic triple-negative breast cancer: Dramatic clinical response to sacituzumab govitecan. | J Dtsch Dermatol Ges | 2024 | 38801008 | PubTator, text mining | PubMed |
| Myositis Autoantibody Profiles and Clinical Significance in Patients with Inflammatory Myopathies in Southwest China. | Clin Lab | 2024 | 38747930 | PubTator, text mining | PubMed |
| Multi-omics integration highlights the role of ubiquitination in endometriosis fibrosis. | J Transl Med | 2024 | 38735939 | PubTator, text mining | PubMed |
| Anti-TIF1-γ Antibody-Positive Dermatomyositis Leading to Identification of Diffuse Large B-Cell Lymphoma. | J Gen Intern Med | 2024 | 38710865 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51592/papers?page=10